Johnson & Johnson to open 3D bioprinting lab at Trinity College Dublin

AMBER, the Science Foundation Ireland-funded materials science institute headquartered at Trinity, today announced a new strategic collaboration with Johnson & Johnson Services, Inc. to establish a collaborative laboratory focused on 3D bioprinting.

Research projects will focus initially in orthopaedics and, in the long-term, offer its internal scientific experts as adjunct professors and engage in staff exchanges. The new Global Centre of Excellence for 3D bioprinting will transform healthcare delivery for patients and consumers. It is due to be operational by the end of 2018.

The announcement was welcomed by Minister for Business, Enterprise and Innovation, Heather Humphreys TD, who said: “Because of the fantastic success of the SFI Research Centre, AMBER, Ireland has a worldwide reputation for excellence in 3D bioprinting and is a global leader in materials science. I am delighted to welcome this new collaboration and look forward to its success moving forward.”

Vice President Supply Chain, Johnson & Johnson Medical Devices Companies, Wim Appelo: “Transforming healthcare delivery for patients and consumers through 3D printing technology requires collaboration with experts from around the world. Our work with AMBER will advance opportunities to design and deliver a broad range of personalised, bioprinted healthcare solutions for the patients and consumers we serve every day.”

The focus for the new research laboratory will be 3D bioprinting, co-led by AMBER’s Professor Daniel Kelly and Senior Fellow, Lead API and Bioprinting at Johnson & Johnson, Joseph Ault.

The collaborative laboratory will establish a work space for Johnson & Johnson scientists and Trinity academicians to engage in collaborative research. 3D bioprinting has emerged as a promising technology for engineering 3D ‘living’ biological tissues for promoting bone and tissue regeneration.

Professor Michael Morris, AMBER Director said, “This lab is the result of a shared vision to create a global centre of excellence for 3D bioprinting within the Centre. This has been made possible because of the calibre of our world leading academics, state of the art equipment and supporting facilities and infrastructure.

Source: tcd.ie

Read more…

Leave a Reply

Your email address will not be published. Required fields are marked *